Highlights and Quick Summary
- EBT margin for the quarter ending December 31, 2022 was -38650.0% (a -Infinity% decrease compared to previous quarter)
- Year-over-year quarterly EBT margin increased by 466.47%
- Annual EBT margin for 2022 was -24942.47% (a -0.0% decrease from previous year)
- Annual EBT margin for 2022 was -24942.47% (a 6.01% increase from previous year)
- Annual EBT margin for 2021 was -23528.81% (a -0.0% decrease from previous year)
- Twelve month EBT margin ending December 31, 2022 was -21662.07% (a -Infinity% decrease compared to previous quarter)
- Twelve month trailing EBT margin decreased by -3.97% year-over-year
Trailing EBT margin for the last four month:
| 31 Dec '22 | 30 Sep '22 | 30 Jun '22 | 31 Mar '22 |
|---|---|---|---|
| -21662.07% | 0.0% | -24277.33% | -22557.89% |
Visit stockrow.com/BNTC
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EBT margin of Benitec Biopharma Limited
Most recent EBT marginof BNTC including historical data for past 10 years.Interactive Chart of EBT margin of Benitec Biopharma Limited
Benitec Biopharma Limited EBT margin for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | -38650.0% | 0.0% | 0.0% | -6822.92% | -24942.47% |
| 2021 | -19284.0% | 0.0% | -200150.0% | -390900.0% | -23528.81% |
| 2020 | -325200.0% | -4941.82% | 8152.78% | -7507.14% | -8111.76% |
| 2019 | – | – | -2714.29% | -3475.76% | 21.39% |
| 2018 | – | – | – | – | -247.29% |
| 2017 | – | – | – | -327.66% | -51.29% |
| 2016 | – | – | – | 12.81% | -611.21% |
| 2015 | – | – | – | – | -289.75% |
| 2014 | – | – | – | – | -545.49% |
| 2013 | – | – | – | – | -238.21% |
Business Profile of Benitec Biopharma Limited
Sector: Healthcare
Industry: Biotechnology